Status: Recruiting
Evaluating the Efficacy and Tolerability of ZED1227 in Subjects With Non-responsive Celiac Disease
A study to discover if ZED1227 can improve continued celiac disease symptoms despite a gluten-free diet
Participants needed: 356
Trial details
Phase: Phase 2Age: 18-80Biological sex: AllType: InterventionalSponsor: Dr. Falk Pharma GmbHUpdated: Apr 2, 2026Locations: 1
Eligibility criteria
Signed informed consent [+4]
Presence of hypo- or hyperthyroidism. A patient with a well-controlled thyroid d... [+4]